nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Brief Survey of First-in-Human Studies
|
Wexler, David |
|
2011 |
51 |
7 |
p. 988-993 |
artikel |
2 |
Bioavailability Considerations in Evaluating Drug-Drug Interactions Using the Population Pharmacokinetic Approach
|
Duan, John Z. |
|
2011 |
51 |
7 |
p. 1087-1100 |
artikel |
3 |
Clinical Pharmacokinetics of Tonapofylline: Evaluation of Dose Proportionality, Oral Bioavailability, and Gender and Food Effects in Healthy Human Subjects
|
Li, Zhaoyang |
|
2011 |
51 |
7 |
p. 1004-1014 |
artikel |
4 |
Coadministration With Lopinavir and Ritonavir Decreases Exposure to BILR 355, a Nonnucleoside Reverse Transcriptase Inhibitor, in Healthy Volunteers
|
Huang, Fenglei |
|
2011 |
51 |
7 |
p. 1061-1070 |
artikel |
5 |
Creation of a Knowledge Management System for QT Analyses
|
Tornøe, Christoffer W. |
|
2011 |
51 |
7 |
p. 1035-1042 |
artikel |
6 |
Effect of Tipranavir/Ritonavir Combination on the Pharmacokinetics of Tadalafil in Healthy Volunteers
|
Garraffo, R. |
|
2011 |
51 |
7 |
p. 1071-1078 |
artikel |
7 |
Food Effect and Biocomparison of Two Formulations of the Dual Orexin Receptor Antagonist Almorexant in Healthy Male Subjects
|
Hoch, Matthias |
|
2011 |
51 |
7 |
p. 1116-1121 |
artikel |
8 |
High Level of Proteinuria During Treatment With Renin–Angiotensin Inhibitors Is a Strong Predictor of Renal Outcome in Nondiabetic Kidney Disease
|
Xie, Di |
|
2011 |
51 |
7 |
p. 1025-1034 |
artikel |
9 |
Incidence and Contributors to Potential Drug-Drug Interactions in Hospitalized Patients
|
Reimche, Leanne |
|
2011 |
51 |
7 |
p. 1043-1050 |
artikel |
10 |
Microneedles: A Valuable Physical Enhancer to Increase Transdermal Drug Delivery
|
Escobar-Chávez, José Juan |
|
2011 |
51 |
7 |
p. 964-977 |
artikel |
11 |
N-acetyltransferase-2 (NAT2) Gene Polymorphisms and Enzyme Activity in Serbs: Unprecedented High Prevalence of Rapid Acetylators in a White Population
|
Djordjevic, Natasa |
|
2011 |
51 |
7 |
p. 994-1003 |
artikel |
12 |
Pharmacokinetics, Pharmacodynamics, and Safety of Ticagrelor in Volunteers With Mild Hepatic Impairment
|
Butler, Kathleen |
|
2011 |
51 |
7 |
p. 978-987 |
artikel |
13 |
Population Pharmacokinetic Model of Human Insulin Following Different Routes of Administration
|
Potocka, Elizabeth |
|
2011 |
51 |
7 |
p. 1015-1024 |
artikel |
14 |
Preventive Effects of Lansoprazole and Famotidine on Gastric Mucosal Injury Induced by Low-Dose Aspirin in Helicobacter pylori–Negative Healthy Volunteers
|
Nishino, Masafumi |
|
2011 |
51 |
7 |
p. 1079-1086 |
artikel |
15 |
Response to “Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban”
|
Turpie, Alexander G. G. |
|
2011 |
51 |
7 |
p. 1122-1123 |
artikel |
16 |
Riociguat (BAY 63-2521) and Warfarin: A Pharmacodynamic and Pharmacokinetic Interaction Study
|
Frey, Reiner |
|
2011 |
51 |
7 |
p. 1051-1060 |
artikel |
17 |
Risperidone-Induced QT Prolongation Following Overdose Correlates With Serum Drug Concentration and Resolves Rapidly With No Evidence of Altered Pharmacokinetics
|
Pollak, P. Timothy |
|
2011 |
51 |
7 |
p. 1112-1115 |
artikel |
18 |
Using Team-based Learning to Teach Clinical Pharmacology in Medical School: Student Satisfaction and Improved Performance
|
Zgheib, N. K. |
|
2011 |
51 |
7 |
p. 1101-1111 |
artikel |